• SHC-1 Inhibition Enhances CFTR Surface Localization in Epith

  2026-07-15

  This study systematically dissects the impact of SHC-1 inhibition on the plasma membrane abundance of CFTR channels across different epithelial cell models. The findings clarify cell-type-specific mechanisms that regulate CFTR trafficking, with implications for cystic fibrosis, COPD, and secretory diarrhea research.

• A Tunable Human Intestinal Organoid System: Balancing Renewa

  2026-07-15

  This study introduces a single-condition culture system for human intestinal organoids that enables precise, reversible control over stem cell self-renewal and differentiation. By leveraging small molecule modulators, the platform enhances cellular diversity and proliferative capacity, advancing the utility of organoids for disease modeling and high-throughput applications.

• 2-Hydroxypropyl-β-cyclodextrin: Practical Guidance for Solub

  2026-07-14

  2-Hydroxypropyl-β-cyclodextrin addresses the persistent problem of solubilizing poorly water-soluble, hydrophobic compounds—particularly those with aromatic or phenyl groups—by enabling inclusion complex formation. It is validated for use as a solubility enhancer or drug formulation excipient in pharmaceutical and biochemical research workflows; applications outside these domains are not supported by current documentation.

• Antifungal Imidazoles Inhibit Cryptosporidium AdhE: Screenin

  2026-07-14

  This study identifies antifungal imidazoles as potent inhibitors of the bifunctional aldehyde/alcohol dehydrogenase (AdhE) in Cryptosporidium parvum, demonstrating low micromolar efficacy in vitro. These findings highlight a new enzymatic target for anti-cryptosporidial drug discovery and illustrate the value of high-throughput screening approaches for pinpointing cell-permeable bioactive compounds.

• Phosbind Acrylamide: Precision Phosphate-Binding Reagent in

  2026-07-13

  Phos binding reagent (Phosbind) acrylamide enables direct, antibody-free differentiation of phosphorylated proteins during SDS-PAGE, accelerating protein phosphorylation analysis within the 30–130 kDa window. Its robust phosphate-binding chemistry empowers researchers to dissect complex signaling events and kinase activities with exceptional sensitivity.

• Weight Loss Restores Intestinal Stretch-Induced Satiety in O

  2026-07-13

  This study uncovers that intestinal stretch acutely suppresses food intake and improves glucose tolerance, but these effects are diminished in obesity and restored by weight loss. The findings highlight a GLP-1-independent mechanism, refining our understanding of gut-derived satiety signals and their relevance to metabolic disease interventions.

• Optimizing Your Glucose Uptake Assays with the WST-8 Kit

  2026-07-12

  Unlock high-sensitivity, non-radioactive quantification of cellular glucose uptake using the WST-8 Glucose Uptake Assay Kit. Learn how experimental tweaks—such as ionic supplementation and workflow streamlining—can elevate your metabolic and disease research while avoiding common pitfalls.

• WST-8 Glucose Uptake Assay Kit: Illuminating Metabolic Dysre

  2026-07-10

  Explore how the WST-8 Glucose Uptake Assay Kit advances cellular glucose metabolism research, with new insights into autophagy, insulin resistance, and NAFLD. This article delivers technical depth and unique perspectives not found in standard assay guides.

• Miltefosine in Hematology: Protocols for Leukopenia and Beyo

  2026-07-09

  Miltefosine, also known as hexadecyl 2-(trimethylazaniumyl)ethyl phosphate, is redefining experimental hematology by targeting both PI3K/Akt inhibition and Ras/MEK/ERK pathway activation. This guide delivers practical protocols, troubleshooting insights, and advanced applications for leveraging Miltefosine in neutrophil differentiation and leukopenia models, all grounded in the latest translational research.

• Tropifexor (LJN452): Uncovering FXR Modulation in Intestinal

  2026-07-09

  Explore the unique role of Tropifexor (LJN452) as a potent FXR signaling pathway modulator, with a deep dive into its impact on intestinal epithelial barrier function and neonatal injury models. Discover new insights beyond standard protocols and learn how this APExBIO compound advances metabolic disease research.

• Deferiprone: Bridging Iron Metabolism and Translational Rese

  2026-07-08

  Deferiprone (3-hydroxy-1,2-dimethylpyridin-4-one) is redefining how translational researchers interrogate iron-dependent cellular mechanisms, from cancer biology to enterocyte metabolism. By fusing recent mechanistic discoveries with actionable protocol guidance, this article articulates how APExBIO’s Deferiprone empowers investigators to dissect, manipulate, and ultimately translate iron stress responses into new therapeutic hypotheses.

• Halazone: Applied Workflows for Water Disinfection & Neuroph

  2026-07-08

  Halazone, an advanced antimicrobial sulfonamide derivative, delivers rapid, quantifiable water disinfection and unique sodium channel modulation in neurophysiological research. This guide translates recent mechanistic findings into actionable protocols, troubleshooting insights, and comparative advantages for scientists seeking reliable performance with APExBIO’s Halazone.

• 5X Protein Loading Buffer (Reducing): Technical Use and Prot

  2026-07-07

  5X Protein Loading Buffer (Reducing) enables thorough denaturation and disulfide bond reduction for accurate protein molecular weight separation in SDS-PAGE workflows. It is suitable for applications requiring reducing conditions but should not be used if native protein conformation or non-reducing environments are needed.

• Carvacrol (5-Isopropyl-2-Methylphenol) in Cell Cycle & Redox

  2026-07-07

  Carvacrol, a multifunctional monoterpene phenol, empowers high-precision cell cycle and redox research through its unique action on apoptosis and TRP channels. This guide details protocol enhancements, troubleshooting, and advanced applications, drawing on the latest TRPV1/TRPA1 redox sensing research to maximize experimental clarity and reproducibility.

• Cy3 Rabbit Anti-Goat IgG (H+L) Antibody: Technical Applicati

  2026-07-06

  The Cy3 Rabbit Anti-Goat IgG (H+L) Antibody addresses the need for highly specific and sensitive detection of goat primary antibodies in fluorescence-based workflows such as ICC/IF, IHC, flow cytometry, and ELISA. It should not be used with non-goat primaries or outside validated immunodetection formats, and careful workflow adherence is required to avoid spectral overlap and sample compatibility issues.

16091 records 1/1073 page Next 12345 下5页 Last page